Method of treating chronic obstructive pulmonary disease (CPD) with verproside
US-10172816-B2 · Jan 8, 2019 · US
Yungjin Pharmaceutical Co Ltd patents
Yungjin Pharmaceutical Co Ltd holds 13 patents in our database, with recent filings and technology areas summarized below.
| Metric | Value |
|---|---|
| Total patents | 13 |
| Recent patents | 0 |
| First publication | Feb 25, 2016 |
| Latest publication | Jan 8, 2019 |
Filing trend
Year-over-year patent counts for this assignee.
Recent patents
Latest publications where this party is an assignee.
Purified extract (ATC1) isolated from Pseudolysimachion rotundum var. subintegrum containing abundant amount of active ingredient, the preparation thereof, and the composition comprising the same as an active ingredient for preventing or treating inflammation, allergy and asthma
US-10046019-B2 · Aug 14, 2018 · US
Method of treating inflammation, allergy and asthma with a purified extract (ATC1) isolated from Pseudolysimachion rotundum var. subintegrum containing abundant amount of active ingredient
US-9999646-B2 · Jun 19, 2018 · US
A novel compound (KS-513) isolated from Pseudolysimachion rotundum var. subintegrum, the composition comprising the same preventing or treating allergic disease, inflammatory disease, asthma or chronic obstructive pulmonary disease and the use thereof
US-2018105548-A1 · Apr 19, 2018 · US
Method Of Treating Chronic Obstructive Pulmonary Disease (CPD) With Verproside
US-2017266142-A1 · Sep 21, 2017 · US
Notable patents
Representative or frequently cited publications from precomputed assignee stats.
Method of treating chronic obstructive pulmonary disease (CPD) with verproside
US-10172816-B2 · Jan 8, 2019 · US
Purified extract (ATC1) isolated from Pseudolysimachion rotundum var. subintegrum containing abundant amount of active ingredient, the preparation thereof, and the composition comprising the same as an active ingredient for preventing or treating inflammation, allergy and asthma
US-10046019-B2 · Aug 14, 2018 · US
Method of treating inflammation, allergy and asthma with a purified extract (ATC1) isolated from Pseudolysimachion rotundum var. subintegrum containing abundant amount of active ingredient
US-9999646-B2 · Jun 19, 2018 · US
A novel compound (KS-513) isolated from Pseudolysimachion rotundum var. subintegrum, the composition comprising the same preventing or treating allergic disease, inflammatory disease, asthma or chronic obstructive pulmonary disease and the use thereof
US-2018105548-A1 · Apr 19, 2018 · US
Method Of Treating Chronic Obstructive Pulmonary Disease (CPD) With Verproside
US-2017266142-A1 · Sep 21, 2017 · US
Technology areas
Mapped technology topics for this assignee.
| Technology | Patents |
|---|---|
| Human Necessities | 13 |
| Operations & Transport | 4 |
| Chemistry & Metallurgy | 2 |
Frequently asked questions
Answers are generated from the same data shown on this page.
- How many patents does Yungjin Pharmaceutical Co Ltd have in patentsdb?
- Yungjin Pharmaceutical Co Ltd is linked to 13 publications as assignee in our database.
- What technology areas does Yungjin Pharmaceutical Co Ltd patent most?
- Top mapped technology areas by patent count: Human Necessities (13); Operations & Transport (4); Chemistry & Metallurgy (2).
- Is Yungjin Pharmaceutical Co Ltd's patent activity growing?
- In our data, assignee counts were 3 in 2018 and 1 in 2019 (lower year over year).
- What are recent patents assigned to Yungjin Pharmaceutical Co Ltd?
- See the “Recent patents” section above for the latest 5 publications we attribute to this assignee.